Stay updated on Aurinia Pharmaceuticals Press Releases

Sign up to get notified when there's something new on the Aurinia Pharmaceuticals Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Aurinia Pharmaceuticals Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    Replace a past financial results item with a forward-looking press update about upcoming data presentations for LUPKYNIS at major conferences.
    Difference
    8%
    Check dated 2025-10-19T16:23:55.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Update: new content highlights including growth, AUR200, Japan approval, and real-world data; older versioned headlines removed.
    Difference
    41%
    Check dated 2025-10-12T14:19:14.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Updated corporate update: removes the Q2 results release notice from 2024 and adds a 2025 response post, signaling a shift in published company communications.
    Difference
    5%
    Check dated 2025-10-05T09:35:01.000Z thumbnail image
  4. Check
    81 days ago
    Change Detected
    Summary
    Aurinia Pharmaceuticals has updated its financial reporting date to July 31, 2025, while removing a previous announcement regarding participation in investor healthcare conferences scheduled for July 2, 2024.
    Difference
    6%
    Check dated 2025-08-01T19:27:28.000Z thumbnail image
  5. Check
    88 days ago
    Change Detected
    Summary
    Aurinia Pharmaceuticals has announced the release date for its second quarter 2025 financial and operational results, scheduled for July 31, 2025, while the previous announcement regarding the 2024 Annual General Meeting results has been removed.
    Difference
    6%
    Check dated 2025-07-25T14:54:53.000Z thumbnail image
  6. Check
    109 days ago
    Change Detected
    Summary
    The webpage has been updated with significant news regarding Aurinia Pharmaceuticals, including announcements of positive study results, financial reports, and shareholder recommendations. Notably, the addition of new data on LUPKYNIS® and updates on corporate progress are highlighted.
    Difference
    100%
    Check dated 2025-07-04T04:09:37.000Z thumbnail image

Stay in the know with updates to Aurinia Pharmaceuticals Press Releases

Enter your email address, and we'll notify you when there's something new on the Aurinia Pharmaceuticals Press Releases page.